Malabsorption (Enteropathogenic Escherichia coli)
Overview
Plain-Language Overview
Malabsorption caused by Enteropathogenic Escherichia coli (EPEC) is an infection that affects the small intestine, where nutrients from food are absorbed into the body. This condition leads to diarrhea, which can cause dehydration and poor nutrient absorption. The bacteria attach to the intestinal lining, damaging the cells responsible for absorbing nutrients. As a result, people may experience symptoms like watery diarrhea, abdominal pain, and sometimes fever. This illness mainly affects young children in developing countries and can impact overall growth and health due to nutrient loss.
Clinical Definition
Malabsorption due to Enteropathogenic Escherichia coli (EPEC) is a diarrheal disease characterized by the bacteria's ability to adhere to the small intestinal epithelium, causing attaching and effacing lesions that disrupt microvilli and impair nutrient absorption. EPEC is a major cause of infantile diarrhea in developing countries and leads to secretory diarrhea without producing classic enterotoxins. The pathogenesis involves the type III secretion system injecting bacterial proteins into enterocytes, resulting in cytoskeletal rearrangement and loss of absorptive surface area. Clinically, this manifests as profuse watery diarrhea, dehydration, and malnutrition. Diagnosis is significant due to the risk of severe dehydration and growth retardation in affected children.
Inciting Event
Ingestion of food or water contaminated with enteropathogenic Escherichia coli.
Fecal-oral transmission from an infected individual or contaminated environment.
Outbreaks often occur in daycare centers or communities with inadequate sanitation.
Latency Period
Symptoms typically develop within 1 to 3 days after ingestion of contaminated material.
The incubation period ranges from 12 hours to 5 days depending on bacterial load and host factors.
Diagnostic Delay
Symptoms often mimic other causes of infantile diarrhea, leading to misdiagnosis.
Limited access to stool culture or molecular testing delays identification of EPEC.
Overlap with other diarrheal pathogens causes initial empirical treatment without specific diagnosis.
Clinical Presentation
Signs & Symptoms
Watery diarrhea without blood or mucus is the hallmark symptom of EPEC infection.
Fever is usually absent or low-grade, distinguishing it from invasive bacterial enteritis.
Abdominal cramps and discomfort accompany diarrhea.
Vomiting may occur, especially in children.
Failure to thrive in infants due to chronic malabsorption.
History of Present Illness
Onset of watery diarrhea often without blood or mucus, lasting several days to weeks.
Associated symptoms include vomiting, fever, and signs of dehydration.
Progressive failure to thrive and weight loss may occur due to chronic malabsorption.
Stools are typically non-bloody and may be voluminous, leading to electrolyte imbalances.
Past Medical History
History of recent travel to endemic areas or exposure to contaminated water sources.
Previous episodes of infantile diarrhea or malnutrition increase risk of severe disease.
Lack of immunizations or incomplete vaccination status may be relevant in some settings.
Family History
No specific heritable syndromes are associated with EPEC infection.
Family members may have similar symptoms due to household transmission.
Clusters of diarrheal illness in siblings or close contacts suggest common exposure.
Physical Exam Findings
Signs of dehydration such as dry mucous membranes and decreased skin turgor are common due to profuse diarrhea.
Abdominal tenderness may be present without peritoneal signs.
Malnutrition indicators like weight loss and muscle wasting can be observed in prolonged cases.
Pallor may be noted secondary to electrolyte imbalances or anemia from malabsorption.
Hyperactive bowel sounds may be heard due to increased intestinal motility.
Diagnostic Workup
Diagnostic Criteria
Diagnosis is established by identifying EPEC strains in stool samples using culture and serotyping or molecular methods such as PCR for eae gene encoding intimin, a key adherence factor. Stool microscopy may show no blood or leukocytes, distinguishing it from invasive diarrheas. Clinical presentation with watery diarrhea in infants combined with detection of EPEC confirms the diagnosis. Additional tests exclude other enteric pathogens to support the diagnosis.
Pathophysiology
Key Mechanisms
Adherence of enteropathogenic Escherichia coli (EPEC) to intestinal epithelial cells via bundle-forming pili disrupts microvilli structure.
Formation of attaching and effacing (A/E) lesions causes loss of absorptive surface area leading to malabsorption.
EPEC injects effector proteins through a type III secretion system, altering cytoskeletal architecture and impairing nutrient absorption.
Disruption of tight junctions increases intestinal permeability, contributing to diarrhea and nutrient loss.
EPEC-induced inflammation further damages the mucosa, exacerbating malabsorption and fluid loss.
| Involvement | Details |
|---|---|
| Organs | Small intestine is the primary site of infection and malabsorption in enteropathogenic Escherichia coli infection. |
Colon may be involved in severe cases, contributing to diarrhea and fluid loss. | |
| Tissues | Intestinal mucosa is disrupted by bacterial attachment and effacement, impairing nutrient absorption. |
Brush border microvilli are effaced by enteropathogenic Escherichia coli, leading to decreased absorptive surface area. | |
| Cells | Enterocytes are the primary intestinal epithelial cells affected by enteropathogenic Escherichia coli, leading to malabsorption. |
M cells facilitate bacterial attachment and translocation in the intestinal mucosa during infection. | |
| Chemical Mediators | Intimin is a bacterial adhesion molecule critical for enteropathogenic Escherichia coli attachment to enterocytes. |
Tir (translocated intimin receptor) is injected into host cells by the bacteria to mediate intimate adherence and pedestal formation. | |
Proinflammatory cytokines such as IL-8 are released by infected enterocytes, recruiting neutrophils and contributing to inflammation. |
Treatments
Pharmacological Treatments
Fluoroquinolones
- Mechanism:
Inhibit bacterial DNA gyrase and topoisomerase IV, leading to bacterial DNA replication inhibition.
- Side effects:
Tendonitis
Gastrointestinal upset
QT prolongation
- Clinical role:
First-line
Trimethoprim-sulfamethoxazole
- Mechanism:
Inhibits bacterial folate synthesis by blocking dihydrofolate reductase and dihydropteroate synthase.
- Side effects:
Rash
Hyperkalemia
Bone marrow suppression
- Clinical role:
Alternative
Non-pharmacological Treatments
Maintain adequate hydration with oral rehydration solutions to prevent dehydration from diarrhea.
Implement proper hand hygiene and sanitation to reduce transmission of enteropathogenic Escherichia coli.
Provide nutritional support to address malabsorption and prevent weight loss.
Prevention
Pharmacological Prevention
No specific antibiotic prophylaxis is recommended due to resistance concerns.
Oral rehydration solutions are essential to prevent dehydration during outbreaks.
Non-pharmacological Prevention
Improved sanitation and access to clean water reduce EPEC transmission.
Hand hygiene is critical to prevent fecal-oral spread.
Breastfeeding provides protective antibodies reducing infant risk.
Proper food handling and cooking prevent contamination.
Public health education on hygiene practices decreases incidence.
Outcome & Complications
Complications
Severe dehydration leading to hypovolemic shock if untreated.
Electrolyte disturbances causing cardiac arrhythmias or muscle weakness.
Growth retardation in infants and young children due to chronic malabsorption.
Secondary lactose intolerance from intestinal mucosal damage.
| Short-term Sequelae | Long-term Sequelae |
|---|---|
|
|
Differential Diagnoses
Malabsorption (Enteropathogenic Escherichia coli) versus Giardiasis
Malabsorption (Enteropathogenic Escherichia coli) | Giardiasis |
|---|---|
Infection with the bacterium Enteropathogenic Escherichia coli | Infection with the protozoan parasite Giardia lamblia |
Exposure to contaminated food or water, often in developing countries | Exposure to contaminated water sources or daycare settings |
Isolation of E. coli strains with attaching and effacing lesions on intestinal biopsy or stool culture | Detection of cysts or trophozoites in stool by microscopy or antigen testing |
Malabsorption (Enteropathogenic Escherichia coli) versus Rotavirus infection
Malabsorption (Enteropathogenic Escherichia coli) | Rotavirus infection |
|---|---|
Can affect children but also adults, especially in outbreaks | Primarily affects infants and young children under 5 years |
Usually causes watery diarrhea but may have prolonged symptoms in malnourished children | Acute, self-limited watery diarrhea lasting 3-8 days |
Isolation of E. coli with characteristic virulence factors in stool culture | Detection of viral antigen in stool by enzyme immunoassay |
Malabsorption (Enteropathogenic Escherichia coli) versus Celiac disease
Malabsorption (Enteropathogenic Escherichia coli) | Celiac disease |
|---|---|
Normal villous architecture with bacterial adherence and effacement of microvilli | Villous atrophy with crypt hyperplasia and increased intraepithelial lymphocytes on small bowel biopsy |
No autoimmune antibodies; infection-mediated mucosal damage | Autoimmune response with anti-tissue transglutaminase and anti-endomysial antibodies |
Improvement with appropriate antibiotic or supportive therapy | Improvement with gluten-free diet |
Malabsorption (Enteropathogenic Escherichia coli) versus Chronic pancreatitis
Malabsorption (Enteropathogenic Escherichia coli) | Chronic pancreatitis |
|---|---|
Normal pancreatic enzyme levels; malabsorption due to mucosal damage | Low fecal elastase indicating exocrine pancreatic insufficiency |
Acute or subacute diarrhea without pancreatic insufficiency | Chronic progressive malabsorption with steatorrhea and diabetes mellitus |
No pancreatic abnormalities on imaging | Pancreatic calcifications and ductal irregularities on abdominal imaging |